BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7354081)

  • 1. Isolation and chemical characterization of neutral glycosphingolipids of human neutrophils.
    Macher BA; Klock JC
    J Biol Chem; 1980 Mar; 255(5):2092-6. PubMed ID: 7354081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and structural characterization of human lymphocyte and neutrophil gangliosides.
    Macher BA; Klock JC; Fukuda MN; Fukuda M
    J Biol Chem; 1981 Feb; 256(4):1968-74. PubMed ID: 6780555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mimicry in the recognition of glycosphingolipids by Gal alpha 3 Gal beta 4 GlcNAc beta-binding Clostridium difficile toxin A, human natural anti alpha-galactosyl IgG and the monoclonal antibody Gal-13: characterization of a binding-active human glycosphingolipid, non-identical with the animal receptor.
    Teneberg S; Lönnroth I; Torres López JF; Galili U; Halvarsson MO; Angström J; Karlsson KA
    Glycobiology; 1996 Sep; 6(6):599-609. PubMed ID: 8922955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutral glycosphingolipids in hairy cell leukemia.
    Lee WM; Klock JC; Macher BA
    Biochemistry; 1981 Oct; 20(22):6505-8. PubMed ID: 7306520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the chemical structure of neutral glycosphingolipids in eggs of the sea hare, Aplysia juliana.
    Yamaguchi Y; Konda K; Hayashi A
    Biochim Biophys Acta; 1992 Nov; 1165(1):110-8. PubMed ID: 1420340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta 1-3-N-acetylglucosaminyltransferase in human leukocytes: properties and role in regulating neolacto glycosphingolipid biosynthesis.
    Stults CL; Macher BA
    Arch Biochem Biophys; 1993 May; 303(1):125-33. PubMed ID: 8489255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of erythrocyte Gal alpha 1-3Gal glycosphingolipids with a mouse monoclonal antibody, Gal-13.
    Galili U; Basbaum CB; Shohet SB; Buehler J; Macher BA
    J Biol Chem; 1987 Apr; 262(10):4683-8. PubMed ID: 2435715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in glycosphingolipids accompanying the differentiation of human squamous SQCC/Y1 cells.
    Tatsumura T; Ariga T; Yu RK; Sartorelli AC
    Cancer Res; 1988 Apr; 48(8):2121-4. PubMed ID: 3258184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of glycosphingolipids from human leukocytes. A unique glycosphingolipid pattern in a case of acute myelomonoblastic leukemia.
    Lee WM; Westrick MA; Klock JC; Macher BA
    Biochim Biophys Acta; 1982 Apr; 711(1):166-75. PubMed ID: 6950793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A novel blood group A- and O (H) -antigens--glycosphingolipids from porcine erythrocytes].
    Sako F
    Hokkaido Igaku Zasshi; 1988 Jul; 63(4):534-44. PubMed ID: 3220436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fucosylated glycosphingolipids of human myeloid cells.
    Kong RK; Barrios A; Knapp W; Macher BA
    Arch Biochem Biophys; 1993 Feb; 300(2):677-83. PubMed ID: 8434948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural characterization of intermediates in the biosynthetic pathway of neolacto glycosphingolipids: differential expression in human leukaemia cells.
    Hu J; Stults CL; Holmes EH; Macher BA
    Glycobiology; 1994 Jun; 4(3):251-7. PubMed ID: 7949652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mono- and difucosyl blood group B glycosphingolipids of rat large intestine differ in type of core saccharide.
    Angström J; Falk P; Hansson GC; Holgersson J; Karlsson H; Karlsson KA; Strömberg N; Thurin J
    Biochim Biophys Acta; 1987 Oct; 926(1):79-86. PubMed ID: 3651504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical characterization of a blood group H type pentaglycosylceramide of human small intestine.
    Breimer ME; Karlsson KA; Larson G; McKibbin JM
    Chem Phys Lipids; 1983 Aug; 33(2):135-44. PubMed ID: 6578878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a major neutral glycolipid in PC12 cells as III3Gal alpha-globotriaosylceramide by the method for determining glycosphingolipid saccharide sequence with endoglycoceramidase.
    Shimamura M; Hayase T; Ito M; Rasilo ML; Yamagata T
    J Biol Chem; 1988 Aug; 263(24):12124-8. PubMed ID: 3403562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Had-1, a uridine 5'-diphosphogalactose transport-defective mutant of mouse mammary tumor cell FM3A: composition of glycolipids, cell growth inhibition by lactosylceramide, and loss of tumorigenicity.
    Taki T; Ogura K; Rokukawa C; Hara T; Kawakita M; Endo T; Kobata A; Handa S
    Cancer Res; 1991 Mar; 51(6):1701-7. PubMed ID: 1998961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryptococcus neoformans, Candida albicans, and other fungi bind specifically to the glycosphingolipid lactosylceramide (Gal beta 1-4Glc beta 1-1Cer), a possible adhesion receptor for yeasts.
    Jimenez-Lucho V; Ginsburg V; Krivan HC
    Infect Immun; 1990 Jul; 58(7):2085-90. PubMed ID: 2194958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and structural characterization of human lymphocyte neutral glycosphingolipids.
    Lee WM; Klock JC; Macher BA
    Biochemistry; 1981 Jun; 20(13):3810-4. PubMed ID: 7272278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the expression of Gal alpha 1-3Gal beta 1-4GlcNAc glycosphingolipids in kidney.
    Hendricks SP; He P; Stults CL; Macher BA
    J Biol Chem; 1990 Oct; 265(29):17621-6. PubMed ID: 2211651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monosialogangliosides of human myelogenous leukemia HL60 cells and normal human leukocytes. 2. Characterization of E-selectin binding fractions, and structural requirements for physiological binding to E-selectin.
    Stroud MR; Handa K; Salyan ME; Ito K; Levery SB; Hakomori S; Reinhold BB; Reinhold VN
    Biochemistry; 1996 Jan; 35(3):770-8. PubMed ID: 8547257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.